LifeFlow
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | Seed | ||
N/A | $2.2m | Debt | |
$3.3m | Series A | ||
$2.1m | Series A | ||
$3.1m | Debt | ||
$8.0m | Series A | ||
* | N/A | $3.0m | Debt |
* | $6.3m Valuation: $40.0m | Series B | |
* | $7.5m Valuation: $40.0m | Series B | |
Total Funding | €24.7m |
Recent News about LifeFlow
Edit410 Medical is a healthcare technology company focused on improving emergency care through innovative fluid resuscitation solutions. The company serves hospitals and emergency medical services (EMS) providers, operating primarily in the medical device market. Its flagship product, LifeFlow, is designed to deliver 500ml of fluid in less than 2 minutes, significantly improving the speed and control of fluid delivery during resuscitation. LifeFlow also addresses critical issues in infection control by protecting the syringe from bacterial contamination, thereby reducing hospital-acquired infections. The business model revolves around the sale of its LifeFlow device and related accessories to healthcare institutions. Revenue is generated through direct sales and long-term contracts with hospitals and EMS providers.
Keywords: fluid resuscitation, emergency care, infection control, medical device, hospitals, EMS, rapid delivery, healthcare technology, LifeFlow, bacterial contamination.